Viewing Company Manulife Financial | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

Manulife Financial Stock Symbol: MFC-T

Last Price Recorded: $23.6100 on 2017-06-23

Globe 5 day average
Google Discussions (view only)
yahoo discussion
Bloomberg
Date Signal Expert Opinion Price
2017-06-23 COMMENT David Cockfield

They’ve been doing much better. His big objection is that they have so much focus in the far East. He would rather have more European/North American focus. Prefers Canada Life. Dividend yield of 3.5%.


Price:
$23.610
Subject:
CANADIAN & ETF's
Bias:
UNKNOWN
Owned:
Unknown
2017-06-22 BUY Bruce Campbell (2)

(Market Call Minute) It would be one he would add for financial exposure.  He is expecting a turn in financials for an insurance company.  He would go for RY-T for a bank.


Price:
$23.580
Subject:
CANADIAN & CANNABIS STOCKS
Bias:
BULLISH
Owned:
Unknown
2017-06-16 BUY on WEAKNESS Greg Newman

The 10 year US bond yields hit 2.6% and went back down to about 2.15%. Lower interest rates are not good for this company and they also have some energy exposure. What is good, is that it is trading at about 5% lower than its peers. Also, has a good growth rate of about 8% and has US$ tailwinds. If you can get this at $23, you should be good.


Price:
$24.090
Subject:
CANADIAN DIVIDEND & DEFENSIVE STRATEGIES
Bias:
BULLISH
Owned:
Unknown
2017-06-12 DON'T BUY Larry Berman CFA, CMT, CTA

He does like the insurance space.  It is going to be challenged.  Life expectancies are extending and the higher interest rate liabilities are extending.  He thinks rates stay low for the next decade or two.


Price:
$24.110
Subject:
NORTH AMERICAN - LARGE & ETFs
Bias:
UNKNOWN
Owned:
Unknown
2017-06-07 COMMENT Kash Pashootan

He respects their business and what they are doing in terms of being global, especially with their exposure in China. It also pays a dividend. All of that is positive. The issue he has is that it is a hard stock to make money on. They recently reported earnings having a strong quarter. With their dividend of about 3.3% and trading at 11 or 12 times, that yield and Price to earnings valuation is very much in line with where Canadian banks are right now, and he would rather own Canadian banks.


Price:
$23.190
Subject:
NORTH AMERICAN DIVIDEND & PORTFOLIO CONSTRUCTION
Bias:
UNKNOWN
Owned:
Unknown
2017-06-05 BUY Jim McGovern

The insurance company he would be a buyer of today. The nice thing is the global diversification. You are getting the US business, the asset manager and the underwriting life insurance business, but more importantly you are getting the Asian exposure, in particular China. If you just tuck this away, as rates creep higher globally and the insurance markets heal, it’s a company you need to own.


Price:
$23.510
Subject:
GLOBAL EQUITIES & MACRO STRATEGIES
Bias:
UNKNOWN
Owned:
Unknown
2017-06-02 WAIT Don Vialoux

Technically it has been in a downward trend lately. Seasonality, it is very similar to the banks. We are in a period right now where the stock is probably going to continue to press the support levels. If it holds, that’s great. There is no real rush to be a buyer until you get into early October.


Price:
$23.580
Subject:
TECHNICAL ANALYSIS & SEASONAL INVESTING
Bias:
CAUTIOUS
Owned:
Unknown
2017-05-29 BUY Colin Stewart

Relative to Canadian banks, this will get more leverage to rising interest rates. With rates going to rise, this would be a good one to participate in. Not a bad place to be.


Price:
$23.650
Subject:
NORTH AMERICAN - LARGE (LONG/SHORT STRATEGIES)
Bias:
UNKNOWN
Owned:
No
2017-05-26 COMMENT Stan Wong

He likes the insurers, and feels they are undervalued at this stage. This is trading at about 10X forward earnings, and BV is just over 1.1 or 1.2. Also, pays a pretty decent dividend of 3.4%. The reason it has dropped off along with other insurers is that there has been a bit of a scale back on long-term interest rates, and insurers are really based on where interest rates are going on the 5 and 10 year rates. He likes their exposure in Japan and other parts of Asia.


Price:
$23.700
Subject:
NORTH AMERICAN - LARGE & ETFs
Bias:
UNKNOWN
Owned:
No
2017-05-25 COMMENT Douglas Kee

He likes this company. There was a run up last year on the anticipation of higher interest rates and inflation coming back. That didn’t happen, so the stock has calmed down. Earnings are being reported, and they are good and solid. ROE of about 11%-12%. He likes this longer-term, because it is capital market intensive as well as their growth in Asia.


Price:
$23.690
Subject:
CANADIAN DIVIDEND
Bias:
UNKNOWN
Owned:
Yes
2017-05-16 COMMENT Lorne Steinberg

Canadian Banks versus lifecos? He is a bigger fan of the lifecos. Manulife (MFC-T) and Sun Life (SLF-T) are going to get a big boost from rising interest rates. It is already starting to happen. The yield curve is steepening. Lifecos have been suffering and living with low interest rates for a long time. Both companies are also quite global. They have big presences in the US and in Asia. He sees a better earnings growth over the next few years.


Price:
$23.720
Subject:
Global Value & High Yield Bonds
Bias:
UNKNOWN
Owned:
Unknown
2017-05-15 BUY Bruce Campbell (1)

They reported a good number as well as really good growth in Asia. This is down because of the macro environment since they reported. Both banks and lifecos are down. They will also be a beneficiary of higher rates. Expects it will be around $26.01 year out. It would be a Buy under $24.


Price:
$23.790
Subject:
CANADIAN LARGE
Bias:
OPTIMISTIC
Owned:
Yes
2017-05-08 BUY Ross Healy

GWO-T vs. MFC-T.  MFC-T has the advantage of being a very diversified company, globally.  They have done well from that diversification.  He tends to prefer it to GWO-T, although he might use its weakness to buy.


Price:
$24.660
Subject:
NORTH AMERICAN - LARGE
Bias:
BEARISH
Owned:
Unknown
2017-05-03 COMMENT Kash Pashootan

Move into banks instead? He likes the banks more. This company’s story on paper is pretty good. They’ve gone from being insurance centric to wealth management, which has that reoccurring fees. They’ve done a lot of things well. Interest rates are eventually going to go up, and this company is going to benefit. However, if you are not making money for your shareholders, it is a waste of time. He would make that move.


Price:
$24.130
Subject:
NORTH AMERICAN DIVIDEND & PORTFOLIO CONSTRUCTION
Bias:
UNKNOWN
Owned:
Unknown
2017-05-03 COMMENT Keith Richards

Bought this for his equity platform on its break-out in late 2016, and sold it in the early part of this year. He still holds it in his income platform because it has a pretty darn good dividend. Doesn’t think there is a lot of downside. If you are happy holding the stock and collecting the dividend, there is going to be a fair amount of support at around $22, and he wouldn’t worry about it.


Price:
$24.130
Subject:
TECHNICAL ANALYSIS
Bias:
CAUTIOUS
Owned:
Yes
Showing 1 to 15 of 1,658 entries
<< < 1 2 3 4 5 > >>

No Comments.


You must be logged in to comment.